a Sankara Nethralaya , Shri Bhagwan Mahavir Vitreoretinal Services , Chennai , India.
Ocul Immunol Inflamm. 2018;26(5):753-759. doi: 10.1080/09273948.2016.1249375. Epub 2016 Nov 30.
To determine the clinical features, treatment, and visual outcome in ocular toxocariasis.
A total of 16 cases diagnosed as ocular toxocariasis clinically and/or serologically were analyzed retrospectively.
The mean age of the patients was 22.6 years. Cases were categorized into three clinical types with peripheral granuloma (43.7%) as the most common presentation. Of the patients, 10 (62.5%) had positive serum ELISA for T. canis; five (31.2%) received combination treatment with anthelmintic and corticosteroid, and eight (50%) patients had vitreous surgery. The visual outcome in eyes which underwent surgery was better, however the difference in medically and surgically treated groups was insignificant (p = 0.11). There was also no difference in visual outcome among the three clinical groups (p = 0.20).
Ocular toxocariasis has a varied presentation spectrum. Serum ELISA for T. canis aids in diagnosis. The difference in visual outcome among clinical and treatment groups was insignificant. However, in general, ocular toxocariasis resulted in a poor visual outcome.
确定眼弓蛔虫病的临床特征、治疗方法和视觉预后。
回顾性分析了 16 例临床和/或血清学诊断为眼弓蛔虫病的患者。
患者的平均年龄为 22.6 岁。病例分为三种临床类型，以周边肉芽肿（43.7%）最常见。10 例（62.5%）患者血清 ELISA 对 T. canis 呈阳性；5 例（31.2%）接受驱虫药和皮质类固醇联合治疗，8 例（50%）患者接受玻璃体手术。手术治疗眼的视力预后较好，但药物和手术治疗组之间的差异无统计学意义（p = 0.11）。三种临床类型之间的视力预后也无差异（p = 0.20）。
眼弓蛔虫病的临床表现多样。血清 ELISA 对 T. canis 的检测有助于诊断。临床和治疗组之间的视力预后差异无统计学意义。然而，一般来说，眼弓蛔虫病的视觉预后较差。
